146 related articles for article (PubMed ID: 18668841)
1. The metabolism of salicylazosulphapyridine in ulcerative colitis: II The relationship between metabolites and the progress of the disease studied in outpatients.
Gut; 1973 Aug; 14(8):637-41. PubMed ID: 18668841
[TBL] [Abstract][Full Text] [Related]
2. The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.
Das KM; Eastwood MA; McManus JP; Sircus W
Gut; 1973 Aug; 14(8):631-41. PubMed ID: 4147555
[TBL] [Abstract][Full Text] [Related]
3. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
4. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
[TBL] [Abstract][Full Text] [Related]
5. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
6. Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).
van Hees PA; Tuinte JH; van Rossum JM; van Tongeren JH
Gut; 1979 Apr; 20(4):300-4. PubMed ID: 36332
[TBL] [Abstract][Full Text] [Related]
7. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.
Azadkhan AK; Truelove SC; Aronson JK
Br J Clin Pharmacol; 1982 Apr; 13(4):523-8. PubMed ID: 6121576
[TBL] [Abstract][Full Text] [Related]
8. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites.
Järnerot G; Into-Malmberg MB; Esbjörner E
Scand J Gastroenterol; 1981; 16(5):693-7. PubMed ID: 6119765
[TBL] [Abstract][Full Text] [Related]
9. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Sutherland L; Macdonald JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD000543. PubMed ID: 16625536
[TBL] [Abstract][Full Text] [Related]
10. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Sutherland L; MacDonald JK
Cochrane Database Syst Rev; 2003; (3):CD000543. PubMed ID: 12917894
[TBL] [Abstract][Full Text] [Related]
11. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Macdonald JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD000544. PubMed ID: 16625537
[TBL] [Abstract][Full Text] [Related]
12. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Roth D; Beck P; May G; Makiyama K
Cochrane Database Syst Rev; 2002; (4):CD000544. PubMed ID: 12519547
[TBL] [Abstract][Full Text] [Related]
13. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study.
Ardizzone S; Petrillo M; Molteni P; Desideri S; Bianchi Porro G
J Clin Gastroenterol; 1995 Dec; 21(4):287-9. PubMed ID: 8583101
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.
Christensen LA
Dan Med Bull; 2000 Feb; 47(1):20-41. PubMed ID: 10709142
[TBL] [Abstract][Full Text] [Related]
15. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
Miyachi Y; Yoshioka A; Imamura S; Niwa Y
Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
Allgayer H; Kruis W; Eisenburg J; Paumgartner G
Eur J Clin Pharmacol; 1984; 26(2):275-7. PubMed ID: 6144549
[TBL] [Abstract][Full Text] [Related]
17. [Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment].
Guastavino E; Litwin NH; Heffes Nahmod L; Licastro R
Acta Gastroenterol Latinoam; 1988; 18(2):107-13. PubMed ID: 2908013
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of sulphasalazine.
Das KM; Dubin R
Clin Pharmacokinet; 1976; 1(6):406-25. PubMed ID: 15752
[TBL] [Abstract][Full Text] [Related]
19. Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers.
Tokui K; Asai Y; Arakawa T; Matsumoto T; Nabeshima T
Biol Pharm Bull; 2002 Feb; 25(2):264-7. PubMed ID: 11853180
[TBL] [Abstract][Full Text] [Related]
20. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
Cowan GO; Das KM; Eastwood MA
Br Med J; 1977 Oct; 2(6094):1057-9. PubMed ID: 21720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
